Business Context and Reporting Period
This Form 8-K Current Report was filed by NanoVibronix, Inc. (trading symbol: NAOV) on June 4, 2019, covering events occurring on May 29, 2019. The registrant is an emerging growth company incorporated in Delaware. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and personnel changes.
Material Changes
- Resignation of CFO: Stephen Brown resigned as Chief Financial Officer, effective May 31, 2019. The resignation was not due to any disagreement with the company regarding operations, policies, or practices.
- Appointment of CFO: James S. Cardwell was appointed Chief Financial Officer, effective May 31, 2019.
- Compensation Arrangement: Mr. Cardwell entered into a one-year consulting agreement with an annual compensation of $15,000, payable in equal monthly installments.
Outlook, Risks, and Management Commentary
Management indicated that Mr. Brown will serve as a consultant to ensure an orderly transition of CFO responsibilities. The filing states there are no family relationships between Mr. Cardwell and other directors or officers, and no material transactions involving Mr. Cardwell have occurred since the beginning of the last fiscal year. No specific financial risks, contingencies, or forward-looking guidance regarding business operations were disclosed in this document.
Investor Verification Checklist
- Verify the transition plan for the CFO role to ensure continuity in financial reporting and SEC compliance.
- Review the attached Exhibit 10.1 (CFO Consulting Agreement) for full terms and conditions beyond the summary provided.
- Confirm the company's current financial status in the most recent 10-K or 10-Q, as this 8-K contains no financial data.
- Monitor future filings for the appointment of a permanent CFO if the current arrangement is interim in nature.